{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:24:24Z","timestamp":1791901464045,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretariat of Science Humanities Technology and Innovation","doi-asserted-by":"publisher","award":["814088"],"award-info":[{"award-number":["814088"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117369","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:00:06Z","timestamp":1758783606000},"page":"117369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P3","title":["The progression of metabolic dysfunction-associated steatotic liver disease toward hepatocellular carcinoma in an efficient rat model"],"prefix":"10.1016","volume":"242","author":[{"given":"Linda Vanessa","family":"M\u00e1rquez-Quiroga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Cardoso-Lezama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brisa Rodope","family":"Alarc\u00f3n-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Gait\u00e1n-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osiris Germ\u00e1n","family":"Idelfonso-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo E.","family":"Vargas-Pozada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Pi\u00f1a-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ramos-Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00fal","family":"Villa-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Arellanes-Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-6631","authenticated-orcid":false,"given":"Pablo","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117369_b0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1878-0261.13685","article-title":"MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives","volume":"19","author":"Karin","year":"2024","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40842-024-00187-4","article-title":"From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome \u2013 current insights and future directions","volume":"10","author":"Basil","year":"2024","journal-title":"Clin. Diabetes Endocrinol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117369_b0020","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200346R","article-title":"A new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma","volume":"36","author":"Green","year":"2022","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.bcp.2025.117369_b0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2025.117369_b0030","article-title":"Worldwide burden of liver cancer due to metabolic dysfunction-associated steatohepatitis from 1990 to 2019: insights from the global burden of disease study","volume":"14","author":"Huang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2025.117369_b0035","article-title":"MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives","author":"Karin","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2025.117369_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114845","article-title":"Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma","volume":"195","author":"M\u00e1rquez-Quiroga","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117369_b0045","doi-asserted-by":"crossref","unstructured":"Q.M. Anstee, H.L. Reeves, E. Kotsiliti, O. Govaere, H. M., From NASH to HCC: current concepts and future challenges, Nat. Rev. Gastroenterol. Hepatol. 16(7) (2019) 411-428, 10.1038\/s41575-019-0145-7.","DOI":"10.1038\/s41575-019-0145-7"},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","article-title":"Preclinical models for studying NASH-driven HCC: how useful are they?","volume":"29","author":"Febbraio","year":"2019","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bcp.2025.117369_b0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med. Mol. Morphol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0027-5107(03)00097-6","article-title":"Environmental persistence of chemicals and their carcinogenic risks to humans","volume":"528","author":"Pollack","year":"2003","journal-title":"Mutat. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117369_b0065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117369_b0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ijc.23995","article-title":"Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats","volume":"124","author":"Wang","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2025.117369_b0075","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1002\/cpz1.211","article-title":"The DEN and CCl(4)-induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma","volume":"1","author":"Uehara","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.bcp.2025.117369_b0080","first-page":"7","article-title":"Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases","volume":"6","author":"Ken","year":"2020","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.bcp.2025.117369_b0085","first-page":"1","article-title":"Chronological activation of the NLRP3 inflammasome\/pyroptosis pathway in the progression from metabolic dysfunction-associated fatty liver disease to hepatocellular carcinoma","author":"M\u00e1rquez-Quiroga","year":"2025","journal-title":"Toxicol. Mech. Methods"},{"issue":"3","key":"10.1016\/j.bcp.2025.117369_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-8741(86)90110-8","article-title":"Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles","volume":"17","author":"Hisashi","year":"1986","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2025.117369_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115762","article-title":"Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome\/pyroptosis pathway","volume":"216","author":"Cardoso-Lezama","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100780","article-title":"Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH","volume":"28","author":"Vargas-Pozada","year":"2023","journal-title":"Ann. Hepatol."},{"issue":"17","key":"10.1016\/j.bcp.2025.117369_b0105","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.3390\/ijms23179954","article-title":"Caffeine inhibits NLRP3 inflammasome activation by downregulating TLR4\/MAPK\/NF-\u03baB signaling pathway in an experimental NASH model","volume":"23","author":"Vargas-Pozada","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117369_b0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.20538","article-title":"Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis","volume":"41","author":"Schiffer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2025.117369_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101897","article-title":"Naringenin attenuates early hepatocarcinogenesis induced by a MASH model","author":"M\u00e1rquez-Quiroga","year":"2025","journal-title":"Ann. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117369_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103009","article-title":"Protocol to detect senescence-associated \u03b2-galactosidase and immunoperoxidase activity in fresh-frozen murine tissues","volume":"5","author":"Idelfonso-Garc\u00eda","year":"2024","journal-title":"STAR Protoc."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12876-016-0477-5","article-title":"Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine","volume":"16","author":"Kishida","year":"2016","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12876-020-01467-w","article-title":"Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)\/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF)","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"42","key":"10.1016\/j.bcp.2025.117369_b0135","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.3748\/wjg.v16.i42.5286","article-title":"Histopathology of nonalcoholic fatty liver disease","volume":"16","author":"Brunt","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117369_b0140","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1111\/cas.15925","article-title":"Clinico-histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease","volume":"114","author":"Fujiwara","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2025.117369_b0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2025.117369_b0150","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.3390\/ijms23095146","article-title":"Lipotoxicity as the leading cause of non-alcoholic steatohepatitis","volume":"23","author":"Brankovi\u0107","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117369_b0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","article-title":"Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children","volume":"20","author":"Kleiner","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bcp.2025.117369_b0160","first-page":"38","article-title":"Steatohepatitic hepatocellular carcinoma","volume":"7","author":"Torbenson","year":"2021","journal-title":"Hepatoma Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12672-024-01069-y","article-title":"Role of lipid metabolism in hepatocellular carcinoma","volume":"15","author":"Cheng","year":"2024","journal-title":"Discov. Oncol."},{"issue":"7424","key":"10.1016\/j.bcp.2025.117369_b0170","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature11706","article-title":"How cancer metabolism is tuned for proliferation and vulnerable to disruption","volume":"491","author":"Schulze","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0175","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12876-022-02615-0","article-title":"Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals","volume":"22","author":"Deng","year":"2022","journal-title":"BMC Gastroenterol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117369_b0180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4158\/EP-2019-0342","article-title":"Impact of type 2 diabetes on nonalcoholic steatohepatitis and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"26","author":"Bian","year":"2020","journal-title":"Endocr. Pract."},{"issue":"10","key":"10.1016\/j.bcp.2025.117369_b0185","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.117369_b0190","doi-asserted-by":"crossref","first-page":"HEP36","DOI":"10.2217\/hep-2020-0017","article-title":"Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma","volume":"7","author":"Nahon","year":"2020","journal-title":"Hepat. Oncol."},{"issue":"42","key":"10.1016\/j.bcp.2025.117369_b0195","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.3748\/wjg.v20.i42.15539","article-title":"Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Takahashi","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0200","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20221271","article-title":"Inflammatory processes involved in NASH-related hepatocellular carcinoma","volume":"43","author":"Cannito","year":"2023","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2025.117369_b0205","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.7150\/jca.51346","article-title":"The role of tumor associated macrophages in hepatocellular carcinoma","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2025.117369_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.589908","article-title":"Hepatocellular senescence: immunosurveillance and future senescence-induced therapy in hepatocellular carcinoma","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"issue":"24","key":"10.1016\/j.bcp.2025.117369_b0215","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1097\/CM9.0000000000003439","article-title":"Navigating the complex role of senescence in liver disease","volume":"137","author":"Li","year":"2024","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"4","key":"10.1016\/j.bcp.2025.117369_b0220","article-title":"Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars","volume":"3","author":"Mart\u00ednez-Zamudio","year":"2023","journal-title":"Cell Genom."},{"issue":"5","key":"10.1016\/j.bcp.2025.117369_b0225","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/path.6164","article-title":"Escape from senescence: molecular basis and therapeutic ramifications","volume":"260","author":"Evangelou","year":"2023","journal-title":"J. Pathol."},{"issue":"18","key":"10.1016\/j.bcp.2025.117369_b0230","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.3390\/cancers13184561","article-title":"Cellular plasticity: a route to senescence exit and tumorigenesis","volume":"13","author":"De Blander","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.117369_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114611","article-title":"Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice","volume":"378","author":"Fuentes-Hern\u00e1ndez","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117369_b0240","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/aps.2010.142","article-title":"Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets","volume":"31","author":"Severi","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.bcp.2025.117369_b0250","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ajcn\/79.3.502","article-title":"Model of nonalcoholic steatohepatitis","volume":"79","author":"Lieber","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.bcp.2025.117369_b0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0260","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1038\/srep12931","article-title":"Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis","volume":"5","author":"Schierwagen","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2025.117369_b0265","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ajpath.2014.01.034","article-title":"Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat\/fructose diet and sedentary lifestyle","volume":"184","author":"Dowman","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117369_b0270","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1038\/s41598-024-58587-6","article-title":"Proteomic analysis of DEN and CCl4-induced hepatocellular carcinoma mouse model","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2025.117369_b0275","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117369_b0280","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.bcp.2025.117369_b0285","article-title":"Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma","volume":"12","author":"Nevola","year":"2023","journal-title":"Biology (Basel)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:23:00Z","timestamp":1762096980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S0006295225006343"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117369","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The progression of metabolic dysfunction-associated steatotic liver disease toward hepatocellular carcinoma in an efficient rat model","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117369"}}